14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends
…, D Andrade, H Cohen, MJ Cuadrado, A Danowski… - Autoimmunity …, 2014 - Elsevier
Antiphospholipid Syndrome (APS) is characterized by vascular thrombosis and/or pregnancy
morbidity occurring in patients with persistent antiphospholipid antibodies (aPL). The …
morbidity occurring in patients with persistent antiphospholipid antibodies (aPL). The …
The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force …
MM Abreu, A Danowski, DG Wahl, MC Amigo… - Autoimmunity …, 2015 - Elsevier
The purpose of this task force was to critically analyze nine non-criteria manifestations of APS
to support their inclusion as APS classification criteria. The Task Force Members selected …
to support their inclusion as APS classification criteria. The Task Force Members selected …
Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus
A Danowski, MNL De Azevedo, M PETRI - The Journal of …, 2009 - jrheum.org
Objective. Antiphospholipid syndrome (APS) is characterized by thrombosis (venous and
arterial) and pregnancy loss in conjunction with the lupus anticoagulant, IgG or IgM …
arterial) and pregnancy loss in conjunction with the lupus anticoagulant, IgG or IgM …
Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus …
A Danowski, TS Kickler, M Petri - The Journal of rheumatology, 2006 - jrheum.org
OBJECTIVE: Antibodies to beta2-glycoprotein I (anti-beta2-GPI) are found in a large percentage
of patients with primary or secondary antiphospholipid syndrome (APS). Our aim was to …
of patients with primary or secondary antiphospholipid syndrome (APS). Our aim was to …
[HTML][HTML] Update on antiphospholipid antibody syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by antiphospholipid
antibodies (aPL) associated with thrombosis and/or pregnancy morbidity. Most APS …
antibodies (aPL) associated with thrombosis and/or pregnancy morbidity. Most APS …
Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
A Danowski, L Magder, M Petri - The Journal of Rheumatology, 2006 - jrheum.org
OBJECTIVE: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune
disease characterized by a relapsing-remitting course. When a mild/moderate flare occurs, …
disease characterized by a relapsing-remitting course. When a mild/moderate flare occurs, …
Guidelines for the treatment of antiphospholipid syndrome
A Danowski, J Rego, AM Kakehasi, A Funke… - Revista Brasileira de …, 2013 - Elsevier
The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
arterial and venous thrombosis, gestational morbidity and presence of elevated and …
arterial and venous thrombosis, gestational morbidity and presence of elevated and …
[HTML][HTML] Non-criteria Antiphospholipid Antibodies: a narrative review
…, OA Monticielo, GGM Balbi, A Danowski… - Revista da Associação …, 2020 - SciELO Brasil
The 2006 Revised Sapporo Classification Criteria for Definite Antiphospholipid Syndrome
included as laboratory criteria the tests for antiphospholipid antibodies whose accuracy was …
included as laboratory criteria the tests for antiphospholipid antibodies whose accuracy was …
[HTML][HTML] Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in …
…, OA Monticielo, A Funke, A Danowski… - Advances in …, 2020 - Springer
Background The term Direct Oral Anticoagulants (DOACs) refers to a group of drugs that
inhibit factor Xa or thrombin. Even though their use for treating different thrombotic or …
inhibit factor Xa or thrombin. Even though their use for treating different thrombotic or …
[HTML][HTML] Diretrizes para o tratamento da síndrome do anticorpo antifosfolipídeo
A Danowski, J Rego, AM Kakehasi, A Funke… - Revista Brasileira de …, 2013 - SciELO Brasil
A síndrome do anticorpo antifosfolipídeo (SAF) é uma doença sistêmica autoimune caracterizada
por trombose arterial e venosa, morbidade gestacional e presença de níveis séricos …
por trombose arterial e venosa, morbidade gestacional e presença de níveis séricos …